Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Nebius Group NV (NBIS) Price & Performance

ADMA Biologics IncTrade
Nebius Group NVTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Nebius Group NV — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Nebius Group NV trades at $225.03 (market cap $49.06B). The key difference: Nebius Group NV is far larger — about 22.1× ADMA Biologics Inc's market cap, and Nebius Group NV is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMANBIS
Market Cap
$2.22B$49.06B
Sector
HealthTechnology
52-Week High
$20.38$286.69
52-Week Low
$7.60$64.06
Enterprise Value
$2.29B$49.26B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Nebius Group NV

Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.

Read more on NBIS